Search results
Results from the WOW.Com Content Network
Simvastatin was initially marketed by Merck & Co under the brand name Zocor but is available generically in most countries following the patent expiry. [citation needed] A combination of simvastatin along with ezetimibe is sold under the brand name Vytorin and is jointly marketed by Merck and Schering-Plough. [citation needed]
Generic versions were approved in 2017. [2] The combination preparation is marketed by Merck & Co. under the trade names Vytorin in the US and Inegy in the European Union. In 2018, it was the 349th most commonly prescribed medication in the United States, with more than 800 thousand prescriptions.
Due to patent expiration, most of the block-buster branded statins have been generic since 2012, ... (Vytorin) and ezetimibe/atorvastatin (Liptruzet) in 2017 [214]
Over the past decade, drug companies have become increasingly dependent on blockbuster drugs -- patented specialty drugs that generate more than $1 billion in sales annually. However, when a major ...
Merck might be one of big pharma's largest companies, but this health care leader has had a tough go recently. The company's pessimistic earnings report this week showed just how badly patent ...
For premium support please call: 800-290-4726 more ways to reach us
Rank Brand Name(s) Generic Name Sales Q1 2014 Sales ($000) Change from Q4 2013 Company(ies) Disease/Medical Use First Approval Date Patent Expiration Date [6] [7]; 1: Abilify
It all starts with -- what else -- patent expirations. The company's revenue has nosedived lately, falling 17% year-over-year in 2012 after schizophrenia drug Seroquel lost patent protection last ...